Ex Parte Mostafavi et alDownload PDFPatent Trial and Appeal BoardDec 28, 201512205431 (P.T.A.B. Dec. 28, 2015) Copy Citation UNITED STA TES p A TENT AND TRADEMARK OFFICE APPLICATION NO. FILING DATE 12/205,431 09/05/2008 55499 7590 12/30/2015 Vista IP Law Group, LLP (Varian) 2160 Lundy Avenue Suite 230 San Jose, CA 95131 FIRST NAMED INVENTOR Hassan Mostafavi UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www .uspto.gov ATTORNEY DOCKET NO. CONFIRMATION NO. VM 08-020-US 6823 EXAMINER CAO,PHATX ART UNIT PAPER NUMBER 2817 NOTIFICATION DATE DELIVERY MODE 12/30/2015 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address( es): docketing@viplawgroup.com ev@viplawgroup.com sandra.roe@varian.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte HASSAN MOST AF A VI and SERGEY POVZNER 1 Appeal2014-000244 Application 12/205,431 Technology Center 2800 Before JASON V. MORGAN, JOSEPH P. LENTIVECH, and JOYCE CRAIG, Administrative Patent Judges. MORGAN, Administrative Patent Judge. DECISION ON APPEAL Introduction This is an appeal under 35 U.S.C. § 134(a) from the Examiner's final rejection of claims 1---6, 13-32, and 39-53. Claims 7-9 and 33-35 are withdrawn. App. Br. 10-11, 14. The Examiner indicates claims 10-12 and 36-38 would be allowable if rewritten in independent form. Final Act. 7. We have jurisdiction under 35 U.S.C. § 6(b ). We AFFIRM. 1 Appellants identify Varian Medical Systems, Inc. of Palo Alto, California as the real party in interest. App. Br. 2. Appeal2014-000244 Application 12/205,431 Invention Appellants disclose "methods and systems for monitoring activity of a patient, such as a breathing activity of an infant." Spec. i-f 2. Exemplary Claim Claim 1; reproduced below with key 1 imitations emphasized, is representative: 1. A method of determining a similarity with a portion of a physiological motion, comprising: obtaining a first image of an object; obtaining a second image of the object; determining a level of similarity between the first and second images; and correlating the determined level of similarity between the first and second images with a portion of the physiological motion. Rejections The Examiner rejects claims 1---6, 13-32, and 39-53 under 35 U.S.C. § 102(b) as being anticipated by Jeung (US 6,980,679 B2; Dec. 27, 2005). Final Act. 3-5. The Examiner rejects claims 1---6, 13-32, and 39-53 under 35 U.S.C. § 102(b) as being anticipated by Guem (US 5,107,845; Apr. 28, 1992). Final Act. 5-7. ISSUE Did the Examiner err in finding Guem discloses "determining a level of similarity between the first and second images; and correlating the determined level of similarity between the first and second images with a portion of the physiological motion," as recited in claim 1? 2 Appeal2014-000244 Application 12/205,431 ANALYSIS In rejecting claim 1 as being anticipated by Guem, the Examiner finds Guem's determination of whether an observed scene has changed by determining whether curves a and b, representing gray levels viewed by photodetectors at two instants, discloses determining a level of similarity between first and second images. Final Act. 5---6 (citing Guem Figs. 4A-B, col. 6, 1. 61---col. 7, 1. 11). The Examiner further finds Guem's successive image gray levels comparison and detection of respiratory arrest in the absence of significant variations or in the presence of abnormal variations in compared successive image gray levels discloses correlating the determined level of similarity between the first and second images with a portion of a physiological motion. Final Act. 6 (citing Guem col. 2, 11. 43-68); Ans. 15 (further citing Guem col. 3, 11. 1-3). Appellants contend the Examiner erred because "Guem specifically teaches comparing gray scale levels of the two curves a, b by subtracting these from each other to obtain difference curve c." App. Br. 7 (citing Guem Figures 4A-B, col. 7, 11. 14--16). Thus, Appellants argue "the so-called 'comparison' of curves in Guem is to determine a difference curve, which is not the same as determining a level of similarity between two images." App. Br. 7; see also Reply Br. 8. However, Guem's comparison of curves a and b ascertains whether a scene observed has not changed between two observation instants. Guem col. 6, 1. 65---col. 7, 1. 1. Thus, Guem's comparison distinguishes between whether two images are identical or different-two levels of similarity (i.e., completely similar or not completely similar). Therefore, we agree with the Examiner that Guem discloses "determining a level of similarity between the first and second images." 3 Appeal2014-000244 Application 12/205,431 Appellants further contend the Examiner erred because "Guem actually discloses comparing gray levels of corresponding points in images to determine respiration disorder. There is nothing in the cited passage of Guem that discloses or suggests correlating any level of similarity (between images) with a portion of a physiological motion." App. Br. 8. In particular, Appellants argue Guem's detection, "in the absence of significant variations or in the presence of abnormal variations in the spatial distribution of the gray levels of the points of brightness of success images compared" (Guem col. 2, 1. 68---col. 3, 1. 1), of "respiratory insufficiency, apnoea or dyspnoea" (id. at col. 2, 11. 67---68) does not disclose the claimed limitation, because "[ n ]otably, 'respiratory insufficiency' is a medical condition, and is not any portion of a physiological motion" (Reply Br. 11 ). However, mere attorney argument is not evidence and is thus entitled to little probative value. In re Geisler, 116 F.3d 1465, 1470 (Fed. Cir. 1997). Thus, Appellants do not provide persuasive arguments or evidence distinguishing the claimed portion of a physiological motion from Guem's detection of respiratory insufficiency. Therefore, we agree with the Examiner that Guem discloses "correlating the determined level of similarity between the first and second images with a portion of the physiological motion," as recited in claim 1. Accordingly, we sustain the Examiner's 35 U.S.C. § 102(b) rejection of claim 1 as being anticipated by Guem. We also sustain the Examiner's 35 U.S.C. § 102(b) rejection of claims 2-6, 13-32, and 39-53, which Appellants argue are patentable for similar reasons. See App. Br. 8. Our affirmance of the Examiner's 35 U.S.C. § 102(b) rejection based on Guem is dispositive of the outstanding claims. Accordingly, we do not reach the issues Appellants raise with respect to the Examiner's 35 U.S.C. 4 Appeal2014-000244 Application 12/205,431 § 102(b) rejection based on Jeung. See, e.g., In re Gleave, 560 F.3d 1331, 1338 (Fed. Cir. 2009) (not reaching rejections based on obviousness when claims already are rejected as anticipated). DECISION We affirm the Examiner's decision rejecting claims 1-6, 13-32, and 39-53. No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a). See 37 C.F.R. § 41.50(±). AFFIRMED PS 5 Copy with citationCopy as parenthetical citation